pre-update Archives

Publication

Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19

As the global COVID-19 pandemic continues, unabated and clinical trials demonstrate limited effective pharmaceutical interventions,…

CertaraAugust 22, 2020

Fact Sheet

Regulatory Operations

CertaraAugust 13, 2020

Fact Sheet

Scientific and Medical Communications

CertaraAugust 13, 2020

Blog

Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China

By Yuancheng Chen, Research Associate of Phase 1 Unit, Huashan Hospital, Fudan University, and visiting…

CertaraAugust 7, 2020

Publication

Quantitative Systems Pharmacology approaches for immuno‐oncology: adding virtual patients to the development paradigm

Drug development in oncology commonly exploits the tools of molecular biology to gain therapeutic benefit…

CertaraJuly 26, 2020

Publication

Model‐Informed Drug Repurposing: Viral Kinetic Modeling to Prioritize Rational Drug Combinations for COVID‐19

We hypothesized that viral kinetic modeling could be helpful to prioritize rational drug combinations for…

CertaraJuly 26, 2020

Press Coverage

PharmaTimes: Interview with Demetrius Carter, The Future is Diversity Issue

CertaraJuly 20, 2020

Publication

Salvaging CNS Clinical Trials Halted Due to COVID‐19

The coronavirus disease 2019 (COVID‐19) pandemic has halted many ongoing central nervous system (CNS) clinical…

CertaraJuly 15, 2020

Blog

The Research to Accelerate Cures and Equity (RACE) for Children Act: Changing the Landscape of Pediatric Cancer Drug Development

3 key tips to set your pediatric program up for success with the RACE for…

CertaraJuly 14, 2020

Publication

Mechanistic quantitative pharmacology strategies for the early clinical development of bispecific antibodies in oncology

Bispecific antibodies (bsAbs) have become an integral component of the therapeutic research strategy to treat…

CertaraJuly 14, 2020

pre-update

Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19

Regulatory Operations

Scientific and Medical Communications

Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China

Quantitative Systems Pharmacology approaches for immuno‐oncology: adding virtual patients to the development paradigm

Model‐Informed Drug Repurposing: Viral Kinetic Modeling to Prioritize Rational Drug Combinations for COVID‐19

PharmaTimes: Interview with Demetrius Carter, The Future is Diversity Issue

Salvaging CNS Clinical Trials Halted Due to COVID‐19

The Research to Accelerate Cures and Equity (RACE) for Children Act: Changing the Landscape of Pediatric Cancer Drug Development

Mechanistic quantitative pharmacology strategies for the early clinical development of bispecific antibodies in oncology

Newsletter sign up

Quick links

Solutions

Contact